Acc 2026 Chip Bcis3 Percutaneous

Prof Divaka Perera (Guy's & St Thomas' Hospital and King's College London, UK) joins us to discuss findings from the ...

Aaysha Cader interviews Divaka Perera regarding the

Dr Anuradha Lala-Trindade (Mount Sinai, New York, NY, US) provides her expert analysis of the most impactful late-breaking ...

The CHIP-BCIS3 trial presented at ACC 2026 is the first randomized trial focusing on protected angioplasty in patients with ...

This study investigated whether using a microaxial flow pump to assist the heart during complex arterial procedures offers a ...

This webinar will review revisions to the PCI base codes, the deletion of add-on codes, changes to the introductory language, and ...

Controlled Trial of High-Risk Coronary Intervention With

Dr Purvi Parwani (Loma Linda University Health, US) recaps the standout science from Day 2 of

John Mandrola offers an

Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined onsite by Michiel Voskuil (UMC Utrecht, ...

Manesh Patel, MD, FAHA, president-elect of the American Heart Association, and Brahmajee Nallamothu, MD, MPH, FAHA, ...

00:00 Session Introduction Friday, May 1 2:50 PM ~ 4:07 PM Coronary Theater, Level 1 Moderator(s): Antonio Colombo, ...

Dr Ann Marie Navar (UT Southwestern, US) delivers an expert breakdown of the most clinically impactful updates from the

This focused session addresses optimal treatment strategies for patients with left main and complex bifurcation coronary lesions.

Drs Karim Al-Azizi (Baylor Scott & White The Heart Hospital, Plano) and Babar Basir (Henry Ford Hospital, US) deliver a short, ...

Bifurcation PCI continues to evolve, driven by new evidence, expanding use of drug-coated balloon (DCB) strategies and a ...

Percutaneous